Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel: +47 21 07 81 60
E-mail:

Copyright/Disclaimer

DDD alterations

ATC code	ATC level name	Previous DDD	New DDD

C03DA01	spironolactone	75 mg O	37.5 mg O
J05AB16	remdesivir	0.1 g P	0.12 g P
L01EX08	lenvatinib	18 mg O	20 mg O
L01EX15	pexidartinib	0.8 g O	0.5 g O
L02BA03	fulvestrant	8.3 mg P	16.7 mg P
L04AJ02	ravulizumab	58.9 mg P	70 mg P ¹⁾

1) Refers to SC injection

Last updated: 2024-12-11